Post a Comment Print Share on Facebook
Featured UE Pedro Sánchez PP Estados Unidos Sumar

STATEMENT: LabConnect acquires the scientific consultancy A4P

(Information sent by the signatory company).

- 2 reads.

STATEMENT: LabConnect acquires the scientific consultancy A4P

(Information sent by the signatory company)

Expanding FSP solutions and scientific consulting services that help clients achieve clinical research trial goals faster.

JOHNSON CITY, Tenn., April 22, 2024 /PRNewswire/ -- LabConnect has announced the acquisition of A4P Consulting Ltd (A4P), a scientific consulting firm specializing in bioanalytical and biosample project management, biomarker strategy and logistics solutions in support of clinical and preclinical trials. The combined international team brings unparalleled breadth and depth of technical and scientific expertise to help clients successfully achieve preclinical and clinical trial goals sooner.

A4P is headquartered in Discovery Park, Sandwich, Kent, UK, and has a wholly owned subsidiary in Appenzell, Switzerland. With core expertise in regulated bioanalysis and genomics, biomarker strategy, personalized healthcare, biosample operations and customized logistics solutions, A4P serves a wide variety of clients in a wide range of therapeutic areas.

"A4P was founded more than 12 years ago by four people in the pharmaceutical industry with a vision for how bioanalytical and logistics consulting could be transformed," said Ian James, PhD., co-founder and CEO of A4P. "Bringing together our unique business model with LabConnect opens up exciting opportunities to expand the geographies in which we operate and enhance our service offerings for our customers. I am excited about the future for both our customers and our valued staff."

In partnership with pharmaceutical and biotechnology companies, contract research organizations (CROs), and foundations/non-governmental organizations (NGOs), LabConnect offers innovative core laboratory services and functional service provider (FSP) scientific solutions for clinical trials of all sizes and complexity around the world. As the requirements for clinical trials and the drug development process have become more complex, LabConnect meets these requirements by offering researchers scientific and technical expertise for all laboratory-related needs, advising on strategies for collection of laboratory data and providing end-to-end analysis and logistics solutions tailored to each trial.

This acquisition further cements LabConnect's industry-leading position as a provider of global core laboratory services and science-focused FSP solutions.

"With our complementary experience, expertise and agile work model, our customers have unprecedented access to cutting-edge scientific solutions to support their clinical and preclinical research," said Dawn Sherman, CEO of LabConnect. "By joining forces with A4P, we advance our mission to create healthier communities and improve the lives of patients by accelerating drug development."

About A4P

A4P offers scientific project management and consulting solutions for bioanalytical and biomarker support within preclinical and clinical programs, and scientific logistics. The bioanalytical project management team has experience working with organizations from start-ups to established global entities. A4P offers a solution to ensure program delivery is on time, on budget and in compliance. A4P's logistics team provides managed and fully personalized support for clients. A4P facilitates exceptional service with a proactive single point of contact to manage all logistics requirements. Visit A4PBio.com. Follow us on LinkedIn.

About LabConnect

LabConnect improves lives by partnering with pharmaceutical and biotechnology companies, contract research organizations (CROs), and foundations/non-governmental organizations (NGOs) to accelerate the development of new medicines around the world. LabConnect offers a unique combination of support services through core laboratory services and functional service provider (FSP) solutions that are customized, timely and flexible to meet the evolving study demands from traditional to increasingly clinical trials. more complex. Visit LabConnect.com. Follow us on LinkedIn.

Logo - https://mma.prnewswire.com/media/1819005...

Logo - https://mma.prnewswire.com/media/2392549...

View original content: https://www.prnewswire.com/news-releases/labconnect-adquiere-la-consultoria-cientifica-a4p-302122726.html